Streetbeat News

Stock Prices

TPST

Tempest Therapeutics has announced significant progress in liver cancer treatment, presenting promising efficacy and safety data at the ASCO Annual Meeting 2024. This breakthrough could potentially improve treatment options for liver cancer patients.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:23 am

SIDU

Sidus Space, Inc. (NASDAQ:SIDU) has priced an underwritten public offering of 1,251,700 Class A shares (or Pre-funded Warrants) at $4.50 each, aiming to raise approximately $5.63 million before underwriting discounts and offering expenses. All offered securities are being sold by the Company.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:11 am

AAPL

META

Gene Munster of Deepwater Asset Management compared Meta Platforms Inc.'s competition with Apple Inc. in the AR/VR headset market to the past rivalry between BlackBerry Ltd and Apple in the smartphone market. Munster suggested that Meta might face a similar fate to BlackBerry, which lost its market dominance to Apple's innovative products. Apple is set to launch its Vision Pro mixed-reality headset, while Meta has already released its Quest 3 VR headset. Munster believes that Apple's entry into the market could validate Zuckerberg's vision but also poses a significant threat to Meta, echoing the past when Apple overtook BlackBerry.

Portfolio Pulse from Ananya Gairola

January 30, 2024 | 7:11 am

CNSP

CNS Pharmaceuticals has announced a public offering of 13,333,334 common shares at $0.30 per share, along with Series A and Series B Warrants to purchase an equal number of shares. The warrants are exercisable immediately upon issuance and expire in five years and eighteen months, respectively. The offering is expected to close on or about February 1, 2024, subject to customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:05 am

AMC

JBT

NOC

On CNBC's 'Mad Money,' Jim Cramer advised against investing in AMC Entertainment Holdings Inc. (NYSE:AMC), citing a decline in moviegoers and the stock's poor performance. Instead, he recommended Northrop Grumman Corporation (NYSE:NOC) and John Bean Technologies Corporation (NYSE:JBT), praising NOC's current price and JBT's position in the industrial food sector. AMC's short percent of float has increased, indicating bearish sentiment, despite a revenue increase in Q3.

Portfolio Pulse from Benzinga Neuro

January 30, 2024 | 7:03 am

AAPL

AMZN

GOOG

GOOGL

META

MSFT

NVDA

TSLA

Market strategist Jon Wolfenbarger predicts a significant stock market crash and a year-long recession, citing economic indicators like The Conference Board's Leading Economic Index and an inverted yield curve. Despite strong earnings from tech giants, he warns of overvaluation and potential new bear market lows. His view contrasts with BlackRock's recent upgrade of U.S. stocks and other analysts' mixed outlooks.

Portfolio Pulse from Benzinga Neuro

January 30, 2024 | 7:00 am

General Motors Company (NYSE:GM) is anticipated to report Q4 earnings of $1.16 per share, down from $2.12 per share a year ago, with projected revenue of $38.97 billion, a decrease from $43.11 billion. Cadillac is increasing production of the Lyriq EV. GM's stock closed up 0.3% at $35.28. Analysts have recently adjusted GM's price targets, with the most accurate analysts giving ratings ranging from Buy to Outperform and price targets between $40 and $60.

Portfolio Pulse from Avi Kapoor

January 30, 2024 | 6:56 am

SVM

The NYSE American has approved Silvercorp Metals Inc.'s listing application, which is a significant step forward for the company's proposed acquisition of OreCorp Limited. This approval facilitates the offer by providing Silvercorp with a more prominent platform that could potentially enhance liquidity and investor exposure. The listing on a major U.S. exchange is likely to be viewed positively by investors as it represents a milestone for Silvercorp's growth and expansion strategy.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 6:54 am

HOLI

Hollysys Automation Technologies has rejected a takeover proposal from Dazheng Investment Group due to concerns over financing and instability in the consortium. The Special Committee of Hollysys endorses the deal with Ascendent, challenging the recommendations of proxy advisory firms ISS and Glass Lewis. Hollysys plans to release updated proxy materials detailing recent engagement with Dazheng.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 6:45 am

XIACY

Xiaomi Corporation's first EV, the Xiaomi SU7, is reported to have a top model priced at approximately $50,350. The pricing details, which range from $35,230 to $50,350 for different variants, are yet to be officially confirmed by Xiaomi. The company is known for its high-quality, affordable smartphones and is now entering the EV market, with the SU7 currently in trial production. Morgan Stanley analysts have a positive outlook on Xiaomi's entry into the EV sector.

Portfolio Pulse from Benzinga Neuro

January 30, 2024 | 6:26 am